[1] Yukio N, Yohei M, Tamiko T, et al. Aberrant nuclear/cytoplasmic localization and gene mutation of beta-catenin in classic pulmonary blastoma: beta-catenin immunostaining is useful for distinguishing between classic pulmonary blastoma and a blastomatoid variant of carcinosarcoma. American Journal of Surgical Pathology. 2004;28(7):921-927.
[2] Travis WD, Brambilla E, Burke AP, Marx Z, Nicholson AG, eds. WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart. 4th ed. Lyon, France: IARC; 2015.
[3] Nakatani Y, Masudo K, Miyagi Y, et al. Aberrant nuclear localization and gene mutation of β-catenin in low-grade adenocarcinoma of fetal lung type: up-regulation of the wnt signaling pathway may be a common denominator for the development of tumors that form morules. Modern Pathology.2002;15(6):617-624.
[4] Sekine S, Shibata T, Matsuno Y, et al. β‐Catenin mutations in pulmonary blastomas: association with morule formation. The Journal of Pathology.2003;200(2):214-221.
[5] Koss MN, Hochholzer L, Frommelt RA. Carcinosarcomas of the lung: a clinicopathologic study of 66 patients. Am J Surg Pathol.1999;23:1514-1526.
[6] Pelosi G, Sonzogni A, De Pas T, et al. Pulmonary Sarcomatoid Carcinomas: A Practical Overview. International Journal of Surgical Pathology.2010;18(2):103-120.
[7] Holst V. p53 and K-ras Mutational genotyping in pulmonary carcinosarcoma, spindle cell carcinoma, and pulmonary blastoma: implications for histogenesis. American Journal of Surgical Pathology.1997;21:801-811.
[8] Dacic S, Finkelstein S D, Sasatomi E, et al. Molecular pathogenesis of pulmonary carcinosarcoma as determined by microdissection-based allelotyping. American Journal of Surgical Pathology.2002;26(4):510-516.
[9] Goldstraw P, Crowley JJ. The International Association for the Study of Lung Cancer International Staging Project on Lung Cancer. Journal of Thoracic Oncology.2006;1(4):281-286.
[10] Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics.2009;25:1754-1760.
[11] McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res.2010;20:1297-1303.
[12] Koboldt DC, Zhang Q, Larson DE, Shen D, McLellan MD, Lin L, et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res.2012;22:568-576.
[13] Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res.2010;38:e164-e.
[14] Cingolani P, Platts A, Wang le L, Coon M, Nguyen T, Wang L, et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly.2012;6:80-92.
[15] Newman AM, Bratman SV, Stehr H, Lee LJ, Liu CL, Diehn M, et al. FACTERA: a practical method for the discovery of genomic rearrangements at breakpoint resolution. Bioinformatics.2014;30: 3390–3393.
[16] Schaefer I M, Sahlmann C O, Overbeck T, et al. Blastomatoid pulmonary carcinosarcoma: report of a case with a review of the literature. BMC Cancer.2012; 12(1):424.
[17] Kawachi K, Murakami A, Sasaki T, et al. Blastomatoid carcinosarcoma of the lung. Pathology International.2013;63(7):377-379.
[18] Sakane T, Okuda K, et al. Blastomatoid pulmonary carcinosarcoma: A rare case report and review of the literature. Thoracic Cancer.2018;9:1323-1326.
[19] Rossi G, Cavazza A, Sturm N, et al. Pulmonary carcinomas with pleomorphic, sarcomatoid, or sarcomatous elements. American Journal of Surgical Pathology.2003;27(3):311-324.
[20] Nakatani Y, Kitamura H, Inayama Y, et al. Pulmonary adenocarcinomas of the fetal lung type: a clinicopathologic study indicating differences in histology, epidemiology, and natural history of low-grade and high-grade forms. American Journal of Surgical Pathology.1998;22:399-411.
[21] Nakayama T et al. Classic pulmonary blastoma: a subtype of biphasic pulmonary blastoma. Ann Thorac Cardiovasc Surg.2012;18:125-127.
[22] Morita S, Yoshida A, Goto A, et al. High-grade lung adenocarcinoma with fetal lung–like morphology. American Journal of Surgical Pathology.2013;37:924-932.
[23] Suzuki M, Yazawa T, Ota S, et al. High-grade fetal adenocarcinoma of the lung is a tumour with a fetal phenotype that shows diverse differentiation, including high-grade neuroendocrine carcinoma: a clinicopathological, immunohistochemical and mutational study of 20 cases. Histopathology.2015;67:806-816.
[24] Kock LD, Ismaël Bah, Brunet J, et al. Somatic DICER1 mutations in adult-onset pulmonary blastoma. European Respiratory Journal.2016;47:1879-1882.
[25] De Kock L, Bah I, Wu Y, et al. Germline and somatic DICER1 mutations in a well-differentiated fetal adenocarcinoma of the lung. Journal of Thoracic Oncology.2016;11:e31-e33.
[26] Katoh. Function and cancer genomics of FAT family genes. International Journal of Oncology.2012;41:1913-1918.
[27] Takahashi K, Kohno T, Matsumoto S, et al. Clonality and heterogeneity of pulmonary blastoma from the viewpoint of genetic alterations: A case report. Lung Cancer.2007;57:103-108.
[28] Dacic S, Finkelstein SD, Sasatomi E, Swalsky PA, Yousem SA. Molecular pathogenesis of pulmonary carcinosarcoma as determined by microdissection-based allelotyping. American Journal of Surgical Pathology.2002;26:510-516.